ProfileGDS5678 / 1418770_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 50% 51% 50% 91% 51% 48% 49% 50% 50% 51% 50% 51% 50% 50% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2365650
GSM967853U87-EV human glioblastoma xenograft - Control 23.2112851
GSM967854U87-EV human glioblastoma xenograft - Control 33.1980950
GSM967855U87-EV human glioblastoma xenograft - Control 47.6425691
GSM967856U87-EV human glioblastoma xenograft - Control 53.1895451
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2388648
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.2519249
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1945850
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1690350
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2041451
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1962450
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1986851
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.210550
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2019950